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Background: The intra-operative real-time assessment of tissue viability can potentially
improve therapy delivery and clinical outcome in cardiovascular therapies. Cardiac ablation
therapy for the treatment of supraventricular or ventricular arrhythmia continues to be done
without being able to assess if the intended lesion and lesion size have been achieved. Here, we
report a method for continuous measurements of cardiac muscle microcirculation to provide an
instrument for real-time ablation monitoring. Methods: We performed two acute open chest
animal studies to assess the ability to perform real-time monitoring of creation and size of
ablation lesion using a standard RF irrigated catheter. Radiofrequency ablation and laser
Doppler were applied to di®erent endocardial areas of alive open-chest pig.Results:We performed
two experiments at three di®erent RF ablation energy setting and di®erent ablation times. Per-
fusion signals before and after ablation were found extensively and distinctively di®erent. By in-
creasing the ablation energy and time, the perfusion signal was decreasing. Conclusion: In vivo
assessing the local microcirculation during RF ablation by laser Doppler can potentially be useful to
di®erentiate between viable and nonviable ablated beating heart in real time.
Keywords: Beating heart; RF ablation; perfusion real-time monitoring; myocardial microcirculation.
1. Introduction
Assessment of the myocardial viability is crucial for
several cardiac interventions. Cardiac ablation
(CA) for arrhythmias, coronary revascularization
(angioplasty or coronary artery bypass graft), and
cardiac resynchronization therapy (CRT) all de-
pend on the knowledge about presence, location
and extent of viable or nonviable myocardium.
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CRT operations and CA assist millions of patients
to recover from life-threatening cardiac arrhythmias
globally. A bene¯cial coronary revascularization
intervention requires the patient to have a sub-
stantial amount of viable myocardial tissue.1 CA
creates myocardial ablation lesions to either destroy
arrhythmogenic substrate or to block the arrhyth-
mogenic reentry circuit. The formation of nonviable
tissue in the lesions is vital for the e®ective ablation
procedure. According to various research studies,
the placement of the CRT device remotely from scar
tissue on a heart segment with preserved viability
su±cient improves the outcomes.2,3 Ypenburg et al.
propose the viability and scar tissue assessment as
potential selection criteria for patients eligible for
CRT.4 The need to assess the viability of myocar-
dium necessitated the adoption of various, already
established, imaging techniques. The most preva-
lent are computed tomography (CT), contrast-en-
hanced computer magnetic resonance imaging
(MRI), dobutamine echocardiography, radionuclide
perfusion scans, and positron emission tomography
(PET).5 Although these techniques provide signi¯-
cantly useful evidence for myocardial viability, their
use is limited to preoperative and postoperative
myocardial assessment; hence, they cannot be
employed intraoperatively. Recently, one of the
most developing areas in medicine is the introduc-
tion of optical methods for the diagnosis of biolog-
ical objects in clinical practice.6,7 The physical basis
of optical diagnostic methods includes various
e®ects that occur when the interaction of electro-
magnetic radiation of the visible and near infrared
range (NIR) with randomly inhomogeneous media
with characteristic sizes of inhomogeneities is com-
parable to the wavelength of the probe radiation.
Laser Doppler °owmetry (LDF)1,8 is a reliable
noninvasive method for measuring viability of
human tissue. The technique relies upon the deliv-
ery of NIR laser radiation into a segment of tissue
being scattered by constituent tissue molecules. The
motion of an erythrocyte within the microcircula-
tory system imparts a Doppler frequency shift on
the photons being scattered. As a result, a range of
Doppler shifts is obtained due to the orientation of
microvessels in living tissue and the velocity distri-
bution of erythrocytes. Interference of the Doppler
shifted NIR laser light with light re°ected from
static tissue scattering produces a temporal and
spatial (speckle) interference pattern. A photode-
tector ultimately registers the interference signal
radiation, and estimates of tissue perfusion are
obtained based on the frequency content of the
Doppler signal. This allows for a continuous mea-
surement of tissue perfusion based on the Doppler
shifted and nonshifted photons registered by the
photodetector. Due to these principles, LDF su®ers
from high sensitivity to motion and a reliance on
arbitrary \perfusion units" (PU), limiting clinical
use. However, Kaser et al. referred that LDF has an
important role in clinical outcome since they are
potentially valuable methods in assisting the sur-
geon to make the right decision in critical venous
mesenteric perfusion.9 Likewise, LDF has been
successfully employed for physiological research,10
cancer assessment,11,12 plastic surgery,13 trans-
plantation surgery14 and many tissue and organ
investigations.8,15,16 It follows that LDF is a po-
tential monitoring technique for myocardial viabil-
ity assessment during trans-catheter cardiac
operations. The appropriate dimensioning and siz-
ing of the laser optic probe will allow incorporating
them into minimally invasive catheters in order to
be used clinically for the intra-operative myocardi-
um assessment. In this study, the use of LDF for
continuous measurements of cardiac muscle micro-
circulation has been studied, with the purpose of
providing an instrument for radiofrequency (RF)
ablation monitoring. We hypothesized that laser
Doppler perfusion can be used to di®erentiate be-
tween viable and nonviable ablated beating porcine
heart in real time.
2. Methods and Materials
2.1. Ethical approval
This study was conducted at the Utrecht University
Medical Centre (Utrecht, Netherlands). The Ani-
mal Experiment Committee of the University of
Utrecht approved the experimental procedure. Two
adult pigs of either sex (80 2 kg) underwent gen-
eral anaesthesia. Animals were maintained and
tested in accordance with the recommendations of
the Guidelines on the Care and Use of Laboratory
Animals.
2.2. Surgical procedure
The animals were sedated with an intramuscular
injection of 25mg/kg of ketamine hydrochloride and
10mg/kg of xylazine, intubated and mechanically
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ventilated with an oxygen/air mixture (3:2). An-
aesthesia was maintained with 2.5% halothane in-
halation. The electrocardiogram was recorded from
three subcutaneous limb electrodes. A mid-line
thoracotomy was performed to access the porcine
beating heart. The pericardial sac was opened to
expose the epicardium. Pulsating porcine epicardi-
um was ablated using a standard RF irrigated
catheter on di®erent locations of the heart. The
catheter was connected to a standard RF generator
(Stockert EP-Shuttle, Biosense Webster, Ger-
many). The predetermined ablation power levels
were 30, 40, and 50W. Each power level was applied
three times for the time intervals of 20, 40, and 60 s
resulting in 27 combinations of power and time. RF
energy was delivered to achieve ablation lesion of 2–
8mm depth. The catheter tip temperature was
monitored, and the RF energy delivery ceased, if the
temperature exceeded the pre-set temperature limit
of 65C. The portion of ablated muscle was excised
and submitted to histological examination.
2.3. Laser Doppler perfusion
monitoring on the beating heart
The epicardium was stabilized using an octopus
tissue stabilizer (Fig. 1) during ablation and sub-
sequent LDF measurement. The epicardial ablation
lesion was clearly visibly following the RF ablation
protocol. The LDF measurement ¯bre was orthog-
onally placed in the middle of the ablation lesion
with no pressure. We used a diagnostic LDF system
LAKK-M (LAZMA Ltd., Russia). RF ablation and
LDF measurement were applied to di®erent
epicardial areas of alive open-chest pig pre and post
thermal application.17 The LAKK-M LDF system is
based on the laser module using a wavelength of
1064 nm. The laser light was delivered, and the
re°ected secondary light from the tissue was col-
lected through a multiple optical ¯ber probe. The
probing ¯ber had a diameter of 6; the receiving
¯bre had a diameter of 400. The source-detector
spacing was 1.5mm. The perfusion signal obtained
was continuous over time and gave an estimate of
the blood perfusion in a small sampling volume close
to the ¯ber probe. The changes in blood perfusion
per unit time in the probed volume of the tissue
above 1mm3 were provided by the index of blood
microcirculation (Im) calculated according to the
following equation:
Im ¼ K Ner  Va; ð1Þ
where K is the proportional coe±cient, Ner is the
number of erythrocytes and Va is the velocity av-
erage of erythrocytes in measured part of the tissue.
2.4. Data analysis and statistics
The LDF raw perfusion data were sampled at 20Hz,
collected and stored digitally during the study and
processed o®line. The statistical programming lan-
guage R 3.6.1 (R: A Language and Environment for
Statistical Computing) was used for data processing
and statistical analysis. LDF raw data were initially
imported into R and visually inspected; LDF seg-
ments undistorted by motion artifacts were manu-
ally annotated before further processing. We next
applied a bandpass ¯lter of 0.5–2Hz to the LDF
signal. The standard deviation of the pulse ampli-
tude signal was used as a measure of pulsatility of the
perfusion signal. Ablation dose was calculated at the
product of ablation energy and time. Dose response
analysis was performed using linear regression anal-
ysis of perfusion and ablation dose. Perfusion signals
pre- and post-ablation were compared using a t-test
statistic. Tests were considered statistically signi¯-
cant at an alpha-error of p <¼ 0:05.
3. Results
In order to validate the accuracy of the LDF for
monitoring RF ablation and lesion formation, two
Fig. 1. Experimental sample of RF epicardium ablation. Oc-
topus tissue stabilizer (blue tool), was used to immobilize the
ablation area of the beating heart. Black arrows indicate RF
ablation lesions.
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porcine experiments were conducted. Eighty-four
epicardial RF lesions were successfully performed in
both animals. We carried out the full ablation
protocol consisting of 27 measurements twice in pig
once (57 lesions) and once in the second animal (27
lesions). The ablation lesions were clearly visible on
the myocardium (Fig. 1).
The irrigated catheter ablation temperature
correlated weakly with the ablation dose (ablation
duration x RF energy) as expected r ¼ 0:33
p < 0:001) (Fig. 2). The maximum temperature did
not exceed the preset temperature (65C) during
the ablation experiments.
LDF was measured in all 84 ablation experiments
to record the regional perfusion before and after RF
ablation. The optical ¯ber probe was positioned
over the center of the formed lesion with no pres-
sure. Figure 3 shows an example of the registered
LDF-graphs before and immediately after RF ab-
lation. There were no complications associated with
the use of the RF catheter application and LDF
probe.
The LDF measurements were easy to make and
the computer software supplied with the LDF de-
vice allowed simple measurement of mean perfusion
within the endocardium before and immediately
after ablation. No signi¯cant di®erences were ob-
served in local blood perfusion before ablation,
whilst the signals before and after ablation were
distinctively di®erent. LDF perfusion was 24:09
2:45 AU (arbitrary units) before RF ablation, and
declined to 13:64 8:25 AU after RF ablation. The
perfusion results are presented in Table 1. A sta-
tistically signi¯cant reduction by 12% of LDF per-
fusion was already visible at a low RF ablation dose
of 200 Ws. At maximum RF ablation dose, the LDF
perfusion was signi¯cantly reduced compared to
baseline (Fig. 2).
4. Discussion and Conclusion
The physiological assessment of myocardial tissue
and scar tissue can be critically important for car-
diac procedures such as the surgical treatment of
ventricular and supraventricular arrhythmias.4,18
To meet this clinical need, several catheter-based
minimally invasive methods, such as intracardiac
echocardiography, optical coherence tomography
and photoacoustic, are being developed.19–23
The laser Doppler technique presented in this
paper has been evaluated in an in vivo animal
model. Thermal application of the miocardium
Fig. 2. Linear relationship between LDF signal pre- and post-
ablation to RF ablation dose. For the analysis we assess the
pulsatility of the signal. We used the standard deviation of the
perfusion signal as measure of pulsatility.
Fig. 3. Example of registered perfusion signal before (yellow)
and after (blue) epicardium ablation.
Table 1. LDF signals pre- (pre-A) and post-ablation (post-A).
Energy [Ws] LDF pre-A [AU] LDF post-A [AU] p
125 22.32  3.02 21.90  4.04 0.700
200 23.29  4.70 20.56  3.27 0.007
300 24.09  2.45 21.65  4.75 0.032
600 22.92  4.49 13.64  8.25 0.011
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leads to changes in its optical properties and blood
perfusion.24,25
LDF as a technique, due to the mechanism of its
action, is able to provide a very sensitive method for
non- or minimally invasive blood perfusion mea-
surement. Using LDF intra-operatively is advanta-
geous in several ways: it is minimally invasive and
requires no administration of drugs (such as con-
trast agents, etc.) and the use of low-power laser
light is considered to be harmless to the tissue. At
the same time, it was shown when LDF is applied to
the beating heart, large motion artefacts are added
to the signal.26 This study uses the octopus tissue
stabilizer as our tool to avoid motion artefacts in
the ¯rst place (Fig. 1). As a result, Fig. 3 shows
representative recordings of LDF before and after
RF ablation. During ablation, with the increasing of
the RF ablation dose, a signi¯cant decrease in blood
perfusion and increase of the pulse-wave amplitude
were observed (Table 1, Fig. 2). Even slight
increases in ablation dose were associated with a
decrease in both myocardial blood perfusion and
pulse and circadian rhythms. Due to the di±culties
in obtaining accurate and reliable results, there are
rather few studies about LDF measurements on the
beating heart published. As a result, there are no
standard reference methods for myocardial perfu-
sion measurements available.27,28
Despite the pronounced results presented in this
study, the LDF technique requires additional ad-
aptation to clinical use. This is primarily due to a
number of limitations. In this study, we ablated the
porcine epicardium; endocardial ablation poses yet
another challenge due to the high concentration of
erythrocytes, limiting the optical penetration depth
and causing multiple Doppler shift. This leads to
poor signal quality and complicates the interpreta-
tion of the data.7,29,30 A limitation of this study is in
the relatively small number of analyzed ablation
lesions and lack of histological analysis. Further
studies should be conducted, including histological
analysis. Despite these drawbacks, advances are
constantly being made. Advanced signal processing
techniques have been applied by several groups to
overcome movement artifacts inherent to LDF so it
can be used for myocardial microvascular mea-
surements.31–33 In conclusion, this study demon-
strates that a commercially available LDF device,
which has been developed to allow continuous real-
time measurement of local tissue perfusion, can be
used to assess epicardial perfusion in beating
porcine hearts. Our study illustrates that the LDF
technique can be used to evaluate in vivo responses
of the heart microcirculation to ablation.
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